^
    Apply
    IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients (NCT03203005)
    Phase 1/2
    National Cancer Institute, Naples
    Completed
    Last update posted :
    02/05/2020
    Initiation :
    09/18/2017
    Primary completion :
    12/20/2019
    Completion :
    12/20/2019
    HLA-A
    |
    HLA-A*02 • HLA-A*24
    |
    cyclophosphamide • CV8102 • Hepavac (IMA970A) • cyclophosphamide intravenous